IL-10 augments the IFN-γ and TNF-α induced TARC production in HaCaT cells: A possible mechanism in the inflammatory reaction of atopic dermatitis

Journal of Dermatological Science

Volumn 26, Issue 1, 2001, Pages 46-54

  Vestergaard, Christian ^a   Kirstejn, Nicka ^a   Gesser, Borbala ^a   Mortensen, Janne T ^a   Matsushima, Kouji ^b   Larsen, Christian G ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Atopic dermatitis; TARC; Thymus and activation regulated cytokine

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR4; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; IT 9302; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; ATOPIC DERMATITIS; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HELPER CELL; HUMAN; HUMAN CELL; KERATINOCYTE; LYMPHOCYTE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN INFLAMMATION;

CELL LINE, TRANSFORMED; CHEMOKINES, CC; DERMATITIS, ATOPIC; DRUG INTERACTIONS; HUMANS; INFLAMMATION; INTERFERON TYPE II; INTERLEUKIN-10; KERATINOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035029128     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(00)00160-2     Document Type: Article

References (35)

1. Diagnostic features of atopic dermatitis
2. Atopic dermatitis
3. Atopic dermatitis may be a genetically determined dysmaturation of ectodermal tissue, resulting in disturbed T-lymphocyte maturation: a hypothesis
4. Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin?
5. Morphology of atopic eczema
6. Blood eosinophilia in atopic dermatitis
7. Hyperstimulatory CD1a+CD1b+CD36+ Langerhans cells are responsible for increased autologous T lymphocyte reactivity to lesional epidermal cells of patients with atopic dermatitis
8. Different in situ distribution patterns of dendritic cells having Langerhans (T6+) and interdigitating (RFD1+) cell immunophenotype in psoriasis, atopic dermatitis, and other inflammatory dermatoses
9. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis
10. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis
11. Allergen specificity of skin-infiltrating T cells is not restricted to a type-2 cytokine pattern in chronic skin lesions of atopic dermatitis
12. Lesional expression of interferon-gamma in atopic eczema
13. Overexpression of IL-10 in atopic dermatitis. Contrasting cytokine patterns with delayed-type hypersensitivity reactions
14. Identification and induction of keratinocyte-derived IL-10
15. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes
16. IL-10 inhibits cytokine production by activated macrophages
17. Monocyte chemotactic and activating factor (MCAF/MCP-1) has an autoinductive effect in monocytes, a process regulated by IL-10
18. Chemokines
19. Chemokines - chemotactic cytokines that mediate inflammation
20. Identification of single C motif-1/lymphotactin receptor XCR1
21. Molecular cloning of a novel T cell-directed CC chemokine expressed in thymus by signal sequence trap using Epstein-Barr virus vector
22. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4
23. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokine thymus and activation-regulated chemokine and macrophage-derived chemokine
24. Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions
25. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells [In Process Citation]
26. Mast cells of psoriatic and atopic dermatitis skin are positive for TNF-alpha and their degranulation is associated with expression of ICAM-1 in the epidermis
27. Stem cell factor, a novel cutaneous growth factor for mast cells and melanocytes
28. Identification of functional domains on human interleukin 10
29. Keratinocytes as initiators of inflammation [see comments]
30. Localization of monocyte chemotactic and activating factor (MCAF/MCP-1) in psoriasis
31. In vitro transformation and tumor progression: a multistep model for skin carcinogensis
32. HaCaT cell line as a model system for vitamin D3 metabolism in human skin
33. IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach
34. Interleukin 10 treatment of psoriasis: clinical results of a phase 2 trial